SCHEMBL20806197

SCHEMBL20806197

Cc1ccc(-c2ccc(-c3ccc(-c4ccc5c(c4)sc4ccccc45)c4nsnc34)c(F)c2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TNKS O95271 1/20 0.34
▸ TNKS2 Q9H2K2 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ DHODH Q02127 1/20 0.32
▸ ALOX5AP P20292 3/20 0.32
▸ FEN1 P39748 3/20 0.32
▸ PDK2 Q15119 1/20 0.32
▸ GRM2 Q14416 1/20 0.31
▸ LIMK1 P53667 1/20 0.31
▸ ENPP1 P22413 1/20 0.31
▸ GPR3 P46089 1/20 0.31
▸ POLB P06746 1/20 0.30
▸ TDP1 Q9NUW8 1/20 0.30
▸ L3MBTL1 Q9Y468 1/20 0.30
▸ ALOX5 P09917 1/20 0.30
▸ MAOB P27338 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16265267 0.85 RARB (0.36) MAPTDHODH
SCHEMBL18464324 0.82 DHODH (0.44) ALDH1A1MAPTHPGDRAB9ASMN1; SMN2
SCHEMBL21537510 0.82 PDE3B (0.38) RAB9ASMN1; SMN2DHODHALOX5APFEN1
SCHEMBL9917122 0.78 GPR3 (0.52) TNKSTNKS2ALDH1A1MAPTHPGD
SCHEMBL9917189 0.78 GPR3 (0.52) TNKSTNKS2ALDH1A1MAPTHPGD
SCHEMBL15315569 0.75 ALDH1A1 (0.44) TNKSTNKS2ALDH1A1MAPTHPGD
SCHEMBL15315578 0.75 ALDH1A1 (0.44) TNKSTNKS2ALDH1A1MAPTHPGD
SCHEMBL21935453 0.75 PDE3B (0.38) DHODHALOX5APFEN1GRM2
SCHEMBL14515087 0.75 DHODH (0.42) MAPTRAB9ASMN1; SMN2DHODHALOX5AP
SCHEMBL18464325 0.74 DHODH (0.46) TNKSTNKS2RAB9ASMN1; SMN2DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3400271-B1 LIQUID-CRYSTALLINE MIXTURES MERCK PATENT GMBH (DE) 2020-07-22 — — EP disclosed
EP-3458549-B1 LIQUID-CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2020-07-22 — — EP disclosed
EP-3400270-B1 DEVICE FOR REGULATING ENTRY OF LIGHT MERCK PATENT GMBH (DE) 2020-04-29 — — EP disclosed
EP-3129829-B1 LIQUID CRYSTAL MATERIAL MERCK PATENT GMBH (DE) 2019-10-30 — — EP disclosed
US-10344217-B2 Device for controlling the passage of energy, containing a dichroic dye compound MERCK PATENT GMBH (DE) 2019-07-09 — — US disclosed
EP-3004251-B1 DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND MERCK PATENT GMBH (DE) 2019-03-13 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10344217-B2 Device for controlling the passage of energy, containing a dichroic dye compound CRY1, SLC25A1, CRY2 TNKS 3749/4885TNKS2 3589/4885ALDH1A1 700/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback